FTH1P3 and non-small cell lung carcinoma: For example, Zheng et al. suggested that transcription factor E2F1-induced FTH1P3 accelerated gefitinib resistance of non-small cell lung cancer [24]; Yang et al. demonstrated that transcription factor STAT1-induced upregulation of lncRNA LINC01123 predicted poor prognosis and enhanced the progression of endometrial cancer by miR-516b/KIF4A [25].